Farxiga / Forxiga • SGLT2 inhibitor • Kidney function: ≥45 mL/min/1.73m² (or CrCl >50)
The recommended dose of Dapagliflozin (Farxiga/Forxiga) at ≥45 mL/min/1.73m² (or CrCl >50) — with monitoring notes for kidney disease and dialysis.
10 mg once daily. Can be initiated.
Well above the eGFR ≥25 initiation threshold. Expect a 10-20% eGFR dip in the first 2-4 weeks — it is protective, not a reason to stop.
Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.
Full Dapagliflozin (Farxiga/Forxiga) kidney guideDapagliflozin (Farxiga/Forxiga) has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.
Interactive drug-dosing tool